Annual Endowment Report: 2021-2022

ANNUAL ENDOWMENT REPORT

2021-2022

OUR MISSION:

TO BUILD A LONG-TERM ENDOWMENT TO SUPPORT THE FIGHT AGAINST CANCER Mary Bird Perkins has been a leader in the fight against cancer for over 50 years.

Endowed gifts provide longterm sustainability needed to support prevention, research, innovation, education, and patient care and support.

Your gift to the endowment creates a brighter future for our community and helps us triumph over cancer.

TOGETHER WE TRIUMPH At Mary Bird Perkins, triumphing over cancer is at the heart of everything we do. But we don’t do it alone. Your support is what allows us to accomplish our mission of improving survivorship and lessening the burden of cancer.

Together, we discover. The Cancer Center has been able to maintain its place on the leading edge of cancer care thanks to constant discovery fueled by your support. We recruit the brightest minds in cancer, provide the most advanced technology and specialized care, and conduct breakthrough research that propels cancer care forward.

Together, we empower. At Mary Bird Perkins, our priority is establishing a strong physician-patient relationship to empower those we serve to make the best choices for their unique circumstances. We partner with our patients to provide individualized treatment plans with the latest in cancer-specific treatment tools at our fingertips.

Together, we care. Care and compassion are the cornerstones of the patient experience at Mary Bird Perkins. From the moment patients walk through the door, team members comfort patients and provide supportive care throughout the entire treatment process. Patients can rest a little easier, knowing they are receiving the most advanced technology and specialized care available.

With your continued support and visionary investment in the health of our community, we can continue to lead the way in providing enhanced care for patients today, tomorrow and for future generations to come.

Together, we triumph over cancer.

NATHANIEL TANNEHILL

2022-2023 Chair, Board of Directors Mary Bird Perkins Cancer Foundation

TODD STEVENS

President and CEO Mary Bird Perkins Cancer Center 02

2021-2022 FINANCIAL OVERVIEW MARKET VALUE AND ACTIVITY (JULY 1, 2021 – JUNE 30, 2022) BEGINNING ENDOWMENT FUND BALANCE ....................................................................................................................................$21,594,715 The market value of Endowment investment and Receivables as of July 1, 2021 Market values fluctuate with the financial markets.

CONTRIBUTIONS, INTEREST, DIVIDENDS, AND MARKET CHANGE ................................................................................... $2,056,194 EXPENDITURES .................................................................................................................................................................................................

$719,051

Includes grant of $490,727 to Mary Bird Perkins Cancer Center to fund prevention, research, innovation, education, patient care, patient support and survivorship programs.

ENDING ENDOWMENT FUND BALANCE ........................................................................................................................................... $22,931,858 The market value of the Endowed Investments and Receivables as of June 30, 2022.

OVERALL INVESTMENT PERFORMANCE OF -16.19% (NET OF INVESTMENT FEES)

ENDOWMENT SNAPSHOT $3.4 MILLION

TOTAL GRANTED TO MARY BIRD PERKINS CANCER CENTER*

46

5

ENDOWMENT FUNDS

03

NEW ENDOWMENT FUNDS

$3.3 MILLION NEW ENDOWMENT GIFTS

78

NEW ENDOWMENT GIFTS

$22.9 MILLION

ENDOWMENT DOLLARS UNDER INVESTMENT

*Grants from Mary Bird Perkins Cancer Foundation began in 2012.

ENDOWMENT INVESTING As of June 30, 2022, our total endowment value is $22,931,858 with a return of -16.19%. Over the past fiscal year, the market was challenging and volatile; however, we outperformed our benchmark index for the year. Due to generous donor support and fiscally responsible leadership, the endowment continues to grow.

CUMULATIVE RETURNS

$25,000,000 $20,000,000 $15,000,000 $10,000,000 $5,000,000 $-

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Endowment Value

120.0% 100.0%

Since inception, the cumulative investment return is 86.91%.

As a result, the endowment has grown because of stable and consistent performance of the portfolio and management of guiding investment and spending policies.

80.0% 60.0% 40.0% 20.0% 0.0% -20.0% -40.0% 2007 2008 2009 2010

2011

2012

2013

2014 2015 2016

2017

2018

2019 2020 2021

2022

Asset Allocation

ASSET ALLOCATION The endowment allocation — the percent exposure to each asset class is shown as of June 30, 2022.

Endowment investing policies are designed to maximize long-term results at an acceptable level of investment risk. Endowed gifts are invested in Mary Bird Perkins Cancer Foundation’s pooled endowment, a globally diversified portfolio of assets including publicly traded stocks, bonds and alternative investments.

16.39%

16.28%

Large Ca

Large Ca

Internat

Emergi n

6.21% 13.39%

Mid Cap

Large Ca

Mid Cap

7.46%

Small Ca Bonds 6.99% 11.30%

Short Te Cash

4.74%

3.11% 2.19%

7.82%

Alternat

4.13%

04

THE FAVRE FAMILY AWARD FOR INNOVATION: FUELING DISCOVERY AND INVESTING IN THE FUTURE OF CANCER CARE Through a $1 million gift to Mary Bird Perkins Cancer Foundation, Art Favre, chairman of the board of Performance Contractors and longtime Cancer Center board member and supporter, is helping to cultivate pioneering treatments, technologies and services to advance and strengthen creative discoveries to fight cancer.

His gift supports the annual Favre Family Award for Innovation, a competition where physicians and team members submit creative projects for the advancement of cancer care. The winning project receives a grant up to $15,000 to help bring an innovative idea to life – many of which have been put into practice across the Cancer Center’s network.

This prestigious award highlights the importance of investing in innovation, which further fuels the advancement and research needed to lead the way in cancer care in the future.

Past awards have included support for transforming a bi-level positive airway pressure (BiPAP) machine typically used to treat sleep apnea into a device to help lung cancer patients breathe in a more controlled way during radiation treatment and developing Helping Hands, an online registry service that lets cancer patients’ circle of friends and family members conveniently offer assistance with non-medical needs. These groundbreaking solutions have helped improve the quality of cancer care.

05

DR. CHARLES M. SMITH’S LEGACY OF GIVING PROPELS FUTURE DISCOVERY FOR MEDICAL PHYSICS A $7.8 million estate gift from the late Dr. Charles M. Smith is helping advance cancer treatment through a longstanding partnership between LSU and Mary Bird Perkins Cancer Center.

The gift established several major awards named in Dr. Smith’s honor, including the Chief of Physics Award to support research and educational activities and three Faculty Research Scholar Awards to assist graduate student research, as well as an educational fund to support graduate education programs. These funds enhance medical physics initiatives by fostering education and innovation among students and physicists, advancing research opportunities that will improve treatments and recruit the highest quality clinicians in this extremely specialized discipline.

Dr. David Solis, a medical physicist and a recipient of the Dr. Charles M. Smith Faculty Research Award, works behind the scenes to ensure the efficiency and safety of radiation therapy treatment plans for patients. Medical physicists typically split their time between clinical work and research, and this award provides Dr. Solis the essential support necessary to advance his leading-edge research into the power of using artificial intelligence to advance radiation therapy treatment.

“In the world of medical physics, this research could help lead to the discovery of new ideas, technologies, concepts, or models that can lead to future solutions

toward our fight against cancer while also enhancing current treatment capabilities for our patients,” Dr. Solis said.

Dr. Smith’s legacy gift will live in perpetuity pushing the boundaries of modern medicine and propelling cancer care forward in Louisiana. Advancements like this would not be possible without the generous support of donors, like Dr. Smith.

“Mary Bird Perkins’ support for innovation, research and discovery was one of the main reasons I chose to join the program here,” Dr. Solis said. “The level of community support for developing future treatments and technology for cancer care is unparalleled.”

Inaugural Dr. Charles M. Smith Faculty Research Scholar Award and Chief of Physics Award Recipients

DR. CHARLES M. SMITH CHIEF OF PHYSICS AWARD | Jonas Fontenot, Ph.D., MBA Chief Operating Officer

DR. CHARLES M. SMITH FACULTY RESEARCH SCHOLAR AWARDS | Christopher Schneider, Ph.D., DABR Medical Physicist

| Garrett Pitcher, Ph.D., DABR Academic Medical Physicist Program Director for the MBPCC Residency Consortium

| David Solis, Ph.D., DABR Medical Physicist

06

CANCER MOONSHOT: HOW MARY BIRD PERKINS IS EMPOWERING COMMUNITIES AND PATIENTS WITH THE HELP OF GENEROUS SUPPORTERS Dr. Jack Saux, medical oncologist at Mary Bird Perkins Cancer Center in Covington, says preventive screenings and early detection are the keys to improving cancer survivorship and reducing mortality rates by 50% over the next 25 years – an ambitious goal outlined by the federal government’s Cancer Moonshot program.

07

How does the cancer moonshot program propose reaching this goal? By removing barriers to cancer care and providing equitable access to preventative screenings for all Americans.

During the COVID-19 pandemic, many people had routine cancer screenings significantly delayed. According to the National Cancer Institute, an estimated 9.4 million screenings were missed in 2020 alone. As individuals return to a pre-pandemic routine, physicians, including Dr. Saux, a member of Northshore Oncology Associates, are seeing an increase in more developed, late-stage cancers.

“In the coming years, we will see a segment of the population with higher mortality rates from cancer due to the pandemic’s effects on prevention and early detection,” Dr. Saux says.

The Cancer Moonshot initiative hopes to draw attention to this and provide funding to advance treatments and offset the pandemic’s effects— something Mary Bird Perkins Cancer Center has been addressing head on with prevention and screening services administered to patients via safe mobile medical clinics.

Motivated by the exceptional care Ben received from Dr. Saux, the family wanted to pay it forward by helping fund prevention and patient support services, such as free community screenings, including the annual Live Well Northshore event. Additionally, their gift funds support services including nutritional counseling, transportation assistance and other emotional and financial needs. In honor of Ben and his family, and in recognition of their generous gift, the Mary Bird Perkins infusion area in Covington is permanently recognized as the Ben Blanchard Infusion Suite.

Additionally, the Blanchard Foundation created a permanent source of funding to support patients in St. Tammany and Washington Parishes by establishing the Ben Blanchard Memorial Endowment Fund within Mary Bird Perkins Cancer Foundation, ensuring Ben’s legacy lives on and saves lives.

“A lot of people in our community don’t have the insurance or resources to get wellness checks,” says Ben’s father, Mark Blanchard. “Early detection can stop cancer. If you catch it early enough, you can save lives. That’s the bottom line.”

Since 2002, the Cancer Center has provided free comprehensive prevention and screening services to people where they live and work.

Prevention on the Go provides cancer prevention, education and early detection services to detect cancer in its earliest stages, when better treatment outcomes are more likely.

But these prevention and early detection efforts would not be possible without the support from donors like the Blanchard family. After a rare form of bone cancer took Ben Blanchard’s life at age 33, his family created the Ben Blanchard Memorial Foundation.

08

Ellen Sessions supported Mary Bird Perkins well before she had personally been impacted by a cancer diagnosis because she recognized the value of having a top-notch cancer center in Louisiana.

Her support was transformed in 2015 when she faced her own battle with breast cancer.

After her diagnosis, she experienced firsthand the truly exceptional care that all patients at Mary Bird Perkins receive. “I couldn’t have asked for more wonderful people to take care of me throughout my journey,” said Ellen. “Mary Bird Perkins is a place where they treat every patient with love and respect. They care for you like family.”

Her cancer care team in particular holds a special place in her heart. Ellen feels blessed to have had access to such a knowledgeable, compassionate and caring team right here at home. She rests easy knowing she received the best possible care from all of the nurses and providers along the way, including her Mary Bird Perkins oncologists — Dr. Schmeeckle and Dr. Castle — and her surgeon, Dr. Christian with the Baton Rouge Clinic.

The personal experience of a cancer diagnosis has enhanced her commitment to give back to Mary Bird Perkins in honor of her treatment team and to ensure everyone in our community has access to the same level of world-class cancer care.

A loyal Rathbone Society member since her diagnosis, she recently joined the Lipsey Legacy Society by establishing the Ellen Chadwick Sessions Endowed Fund, while also creating a legacy gift by naming Mary Bird Perkins as the beneficiary of her IRA, ensuring her support will live on for years to come.

09

Ellen’s careful estate planning helped enable her to make a transformational investment in the fight against cancer to help those who have faced a cancer diagnosis not only survive, but thrive. Planned giving as part of estate planning allows grateful patients, like Ellen, to create a lasting legacy that ensures future generations receive the same level of exceptional care that she did.

OUR VISION FOR TOMORROW As cancer care rapidly evolves, philanthropy will continue to play a significant role in maintaining the Cancer Center’s leading-edge treatment, technology and innovation and providing unparalleled, state-ofthe-art treatments. Through the continued support of our community, we will unlock resources that will transform the patient experience and help us accomplish our vision for tomorrow of triumphing over cancer.

As part of our recent 50th anniversary, we introduced the Legacy Challenge, a special opportunity to strengthen our endowment and invest in cancer care.

By including Mary Bird Perkins Cancer Foundation in your estate plans, or by establishing an endowed fund, you can join the Legacy Challenge and help us reach our goal of $50 million by 2025, making a difference today and securing the future of cancer care for generations to come.

Through community support, Mary Bird Perkins Cancer Foundation has secured more than $34 million in assets. Matching funds are available, enabling donors to do more than they ever imagined to improve survivorship and lessen the burden of cancer.

Joining the Legacy Challenge is a way to create a personal and lasting legacy and help grow our endowment, adding another layer of security and stability as we advance the fight against cancer.

Because of loyal, forward-thinking partners like you, we can continue to provide the highest quality care to cancer patients across the Gulf South. With your help, together, we can triumph over cancer.

10

A COMMUNITY COMES TOGETHER TO HELP TRIUMPH OVER SKIN CANCER Although Lauren Savoy Olinde stood just five feet tall, she was a larger than life force to those who knew and loved her. Artistic and passionate, she was a born leader who served as president of the student body at St. Joseph’s Academy, as well as president of her sorority, Tri Delta, in college. She worked tirelessly to accomplish her dreams, even continuing to pursue her doctorate of pharmacy degree after being diagnosed with an aggressive melanoma skin cancer, ultimately living out her life-long goal of becoming a pharmacist and helping others.

In 2012, her life was tragically cut short at just 27 years old, but in the wake of their loss, her family and friends came together to form the Lauren Savoy Olinde Foundation with a mission to bring awareness to skin cancer and sun safety through community events and education programs. Led by Lauren’s long-time best friend, Sarah Gray, and supported by her parents, the Lauren Savoy Olinde Foundation helped take the fight against skin cancer forward in our community.

In 2018, the Lauren Savoy Olinde Foundation established an endowed fund through the Mary Bird Perkins Cancer Foundation to continue its work on skin cancer education and early detection programs and services.

In just three short years, the Lauren Savoy Olinde Endowment Fund reached its goal of raising over $100,000 to expand the vital resources needed for skin cancer education and early detection programs in our community and across the region.

Their efforts are a testament to Lauren’s legacy and her passionate fight against skin cancer. A true community effort, the fund was supported by hundreds of Lauren’s friends coming together for a common goal: to endow a fund in Lauren’s honor.

11

“It was a real community effort,” Nancy Olinde, Lauren’s mother, said.

“The outpouring of support in Lauren’s honor came from the way she impacted everyone she came into contact with.”

Lauren’s fund will continue to have a profound impact on patients and their families in the fight against skin cancer and help save and extend the lives of so many.

“Our partnership with Mary Bird Perkins Cancer Foundation has allowed us to extend the reach of Lauren’s fund while keeping it connected to our community,” Sarah Gray said. “We’re grateful for Mary Bird’s stewardship and support of Lauren’s fund and proud to know it will continue Lauren’s fight against skin cancer for years to come.”

Sarah Gray, best friend of Lauren, placing a tribute tile on Our Community Wall at the Cancer Center

THE POWER OF FRIENDSHIP TO CREATE A LASTING LEGACY Sarah Madison Romero was a bright light to all who encountered her. An LSU cheerleader and Chi Omega sorority sister, active in her church and her community, she loved life and showed everyone how to celebrate and live it to the fullest. Upbeat, cheerful and energetic, she also worked tirelessly taking care of her family and friends and loved helping others.

But, life circumstances would dominate the final quarter of her life. A woman of incredible strength and spirit, Sarah faced almost two decades of cancer battles with courage. Over the years, Sarah became passionate about Mary Bird Perkins and embraced the Cancer Center’s mission by becoming a loyal donor. After Sarah’s passing, her longtime best friend, Nancy Nuzum Hodgins, and Nancy’s brother Robert started an endowed fund in Sarah’s honor.

never reach that goal — it seemed like such a challenge,” Nancy said. “But in the end, it was surprisingly easy. Sarah touched so many lives. People wanted to honor her memory and support her as she had done them.”

Their success in reaching the goal of creating an endowed fund shows the power that a group of friends can have to come together in honor of someone important that they have lost.

“She possessed a spirit filled with light and one that was not dimmed by cancer,” said Kim Davis, a long-time friend.

Each year, Nancy, Robert, Sarah’s husband, C.D. Romero, and other longtime friends would invite Sarah’s family and friends to make a gift to the Cancer Center on her birthday to honor her joyful spirit and love of celebrating important milestones.

In 2019, they successfully reached the goal of raising $100,000 to fully endow her fund, ensuring the earnings from her fund will provide the vital resources needed to shape and secure the future of cancer care in our community and beyond.

“When we originally had the idea to create the fund and realized we needed to raise $100,000, we honestly thought we would 12

THE LIPSEY LEGACY OF SUPPORT LIVES ON

The Lipsey Legacy Society, named in honor of Anna B. Lipsey’s dedication to Mary Bird Perkins Cancer Center, recognizes those who have made a contribution to the Foundation through a planned gift or a named endowed fund. Through generous contributions, Society members help keep Anna’s vision for a world-class Cancer Center flourishing and invest in the future of cancer care in our community.

Richard Lipsey and his wife, Susan, have proudly carried on his mother’s legacy through leadership and philanthropy. Richard served on the Cancer Center’s board of directors for 14 years, including two as board chair. Susan also served on the board of directors, advocating for the Cancer Center’s robust volunteer program. In continuing their family’s commitment to Mary Bird Perkins generationally, Richard and Susan’s daughter, Laurie, is a current board member and their daughter, Wendy, is a dedicated volunteer and ambassador.

2021 - 2022

NEW LIPSEY LEGACY SOCIETY MEMBERS • McMains Foundation Endowed Fund McMains Foundation • Tracey and Ty McMains

• Jan and Sanford Roy Family Endowed Fund Jan and Sanford Roy • Tillman Stogner Endowed Fund Tillman Stogner

13

LIPSEY LEGACY SOCIETY MEMBERS • Robelynn H. Abadie • Lisa and Tom Adamek & Family Fund Lisa and Tom Adamek • Mr. and Mrs. John W. Barton, Jr. • Sybil A. Bateman * • Mr. and Mrs. James M. Bernhard, Jr. • Dr. and Mrs. Frederic Billings III Fund Susan and Frederic Billings • The Ben Blanchard Memorial Endowment Fund Susan, Mark and Chris Blanchard • Kim A. Boudreaux • Mrs. Jane Thibaut Boyce * • Mr. and Mrs. John C. Boyce Family Fund Melanie and John Boyce • Kate and Tee Brown • Renee Hebert Bryant Memorial Fund * • Joan* and Herbert H. Butt • Mr. and Mrs. J. H. Campbell, Jr. • Robert R. Casey * • The Ella Chance Family • The Coates Family Fund Beverly and Dudley* Coates • Jess Willard Cockerham * • Charles Newsam Conner * • Theresa Frey Cooper * • Violet T. Crum * • Jean H. and Louis D. Curet Family Fund * • Mr. D. Cecil Delaune * • Ms. Elaine T. Delaune * • Leonard Boyd Delaune * • Wilbon “W. T.” Doughty * • Hazel Ewing * • Isiah J. Ewing * • The Favre Family Fund for Innovation Art E. Favre • William A. Ferguson * • Dr. Robert Fields Patient Care Fund • The Raymond and Mary Gettier Fund * • Charlie V. Giambelluca * • Devera and Jerry Goss Research Fund Devera and Jerry Goss • Isaac and Florence Gregorie * • Mr. and Mrs. G. Lee Griffin • Davis A. Gueymard * • David S. Hanson, MD and Jolene K. Johnson, MD • Mrs. Cecile B. Harrell * • Heart of a Hero Fund • The D. Jensen Holliday Family Fund Estelle and Jensen* Holliday

• Jerry Dale O’Donovan Hornsby* in loving memory of Frank Gore • Jeanne C. and David M. James • Dr. and Mrs. Sheldon A. Johnson • Donna and J. Gerard Jolly • Mr. and Mrs. Robert H. Jones • Esther Kent * • The Shirley C. and J. Barker Killgore Research Fund * • Wojciech Antoni Krotoski * • Mr. and Mrs. Anthony S. Kurlas Family Fund Ginger and Tony Kurlas • L. Perrie Lambert Memorial Fund * • Hillary Lanaux Endowment Fund * Mr. Hilaire Dubertrand* and Mrs. Ethel Langenstein Lanaux • Mary Alicia and Bettye Lauret * • Marianne and R. Upton Lea, Jr. Memorial Fund * • Clifton J. LeBlanc * • Richard A. Lipsey and Susan Haspel Lipsey Family Fund in memory of Anna B. Lipsey Susan and Richard Lipsey Laurie Lipsey Aronson Wendy Lipsey • Pat and Don Lyle • The Wilbur Marvin* Endowment Fund in honor of Donna M. Saurage • Mauti Cancer Fund • Kathy and Frank McArthur • Lady Katharine McLaurin * • Tracey and Ty McMains • McMains Foundation Endowed Fund McMains Foundation • Anne and Tom Meek Endowed Fund Anne and Tom Meek • Marguerite H. Mills * • T.J. Moran Fund Mr. Thomas J. Moran * • Suzanne Motion * • Rosalie Moyse * • Stephen R. Musso * • Rebecca and Dyke Nelson & Family Fund Rebecca and Dyke Nelson • Ron and Corinne Helm Ness • Mrs. Eleanor P. Newman * • Virginia B. and John Noland • Evelyn and Paul Nowacki • Cindy and Craig Nuckolls • The Lauren Savoy Olinde* Endowment Fund

• Robins-O’Quin Endowed Family Fund Gail and Bill O’Quin • The Phillips Family Fund Claudia and Gary Phillips • The David C.* and Jeannie Price Fund • Barbara Virginia Rathbone • The Rathbone Family Fund Barbara Rathbone Randee and Jack Rathbone IV Michele and Richard* Rathbone Shawnee and Steve McCord • Dr. and Mrs. M. J. Rathbone, Jr. * • Michele and Richard* Rathbone • The Dee Dee* and Kevin P. Reilly, Sr.* Endowment Fund • The Sarah Madison Romero* Endowment Fund • Allison and Blanchard Sanchez • Marjorie H. Sanders * • H. N. Saurage IV Family Fund Laurie and Hank Saurage • The Saurage Family Fund • Donna M. Saurage • The Melissa Margaret Mary Savoie Endowment Fund * • Ellen Chadwick Sessions Endowed Fund Ellen C. Sessions • Ms. Ruth C. Sessions * • The Simmons Family Fund Betty Jean Simmons • Beverly Carson Smiley • Dr. Charles M. Smith Medical Physics Fund Dr. Charles M. Smith * • Jan and Sanford Roy Family Endowed Fund Jan and Sanford Roy • Smith-Gwatney Endowed Fund in Honor of Scotty Gwatney Jon S. Gwatney • Bernice* and Edward Spiess • Kelli and Todd Stevens • The Tillman Stogner Endowment Fund Tillman Stogner • Emily C. Stich • Mr. Robert M. Stuart, Sr. • Dr. and Mrs. O. M. Thompson, Jr. • Pam and Mike Wall • The Jean and Will Wilcox Fund Jean and Will Wilcox • Ann Wilkinson • Drs. Charles and Brooke Wood • Anonymous (7) *Fondly Remembered.

14

MEET THE 2021-2022 MARY BIRD PERKINS CANCER FOUNDATION

BOARD OF DIRECTORS ROSE HUDSON Chair

STEVEN MOORE Vice Chair

ROLFE MILLER

SUSAN BLANCHARD TEE BROWN BRETT FURR JEANNE JAMES

Secretary/Treasurer

REBECCA NELSON

JERRY JOLLY

JOSEPH B. “BEAU” OLINDE

Immediate Past Chair

TODD STEVENS

President and CEO

DAVID PERRY NATHANIEL TANNEHILL

EMERITUS BOARD OF DIRECTORS JOHN BARTON, JR. AZA BOWLIN JAY CAMPBELL LOUIS CURET* JERRY GOSS G. LEE GRIFFIN RICHARD LIPSEY

MICK MAULDIN JIM MCILWAIN GAIL O’QUIN BILL PETERS BLANCHARD SANCHEZ PAUL THOMPSON *Fondly Remembered.

HISTORY OF THE FOUNDATION Established on January 1, 2005, the Mary Bird Perkins Cancer Foundation was created by a dedicated group of community members to manage and oversee the successful growth of endowment assets to support Mary Bird Perkins’ mission of improving survivorship and lessening the burden of cancer. The Foundation’s purpose is to build a long-term endowment fund to secure the future of cancer care today, tomorrow and for future generations.

THANK YOU FOR BEING A MEMBER OF THE MARY BIRD PERKINS CANCER FOUNDATION COMMUNITY AND SUPPORTING THE FIGHT AGAINST CANCER. WE ARE GRATEFUL FOR YOUR SUPPORT.

If you would like to enhance your commitment and help us reach our goal of $50 million through the Legacy Challenge, please contact Carter Rose Stone, Senior Director of Development, at (225) 215-1298 or cstone@marybird.com.

4950 ESSEN LANE | BATON ROUGE, LA | 70809 (225) 215-1298 MARYBIRDFOUNDATION.ORG